[1-(6-Cyclopropylamino-pyrimidin-4-yl)-piperidin-3-yl]-methanol, 95.0%, 250mg

N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]propan-2-yl]-3-(1-hydroxyethyl)-1H-pyrazole-5-carboxamide, 95%, 25mg

Methyl 2-(4-bromophenyl)-2-((tert-butoxycarbonyl)amino)acetate, 95%, 1g

Methyl cis-6-Octadecenoate>98.0%(GC)500mg

(1-(4-Nitrophenyl)piperidin-3-yl)methanol, 95.0%, 1g

Flacon à col étroit, 500 ml, 28 mm, 12 pièce(s)

4-(4-Bromopyrazol-1-yl)benzoic acid, 98%, 1g

4-Bromo-7-methyl-1H-indole, 95.0%, 1g

ETHYL 6-BROMO-1H-INDOLE-3-CARBOXYLATE, 95.0%, 10g

Ethyl 4-cyanopicolinate, 97.0%, 1g

3-Bromo-5-hydrazinylpyridine dihydrochloride, 96%, 1g

2-methoxy-4-[(propylamino)methyl]phenol hydrochloride, 95.0%, 1g

6-Nitro-1,2,3,4-tetrahydro-isoquinoline hydrochloride, 95.0%, 25g